Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwill & IntangiblesLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxLong-Term InvestmentsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regional Management (RM) Cash & Equivalents: 2011-2025

Historic Cash & Equivalents for Regional Management (RM) over the last 14 years, with Sep 2025 value amounting to $4.1 million.

  • Regional Management's Cash & Equivalents fell 13.93% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year decrease of 13.93%. This contributed to the annual value of $4.0 million for FY2024, which is 12.38% down from last year.
  • Regional Management's Cash & Equivalents amounted to $4.1 million in Q3 2025, which was down 4.40% from $4.3 million recorded in Q2 2025.
  • Regional Management's Cash & Equivalents' 5-year high stood at $17.6 million during Q1 2022, with a 5-year trough of $3.1 million in Q3 2022.
  • Its 3-year average for Cash & Equivalents is $5.4 million, with a median of $4.3 million in 2024.
  • The largest annual percentage gain for Regional Management's Cash & Equivalents in the last 5 years was 144.05% (2022), contrasted with its biggest fall of 63.14% (2022).
  • Quarterly analysis of 5 years shows Regional Management's Cash & Equivalents stood at $10.5 million in 2021, then crashed by 63.14% to $3.9 million in 2022, then rose by 16.42% to $4.5 million in 2023, then declined by 12.38% to $4.0 million in 2024, then fell by 13.93% to $4.1 million in 2025.
  • Its last three reported values are $4.1 million in Q3 2025, $4.3 million for Q2 2025, and $4.2 million during Q1 2025.